Paradoxical intestinal inhibitory effects of staphylococcal enterotoxin.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001464:Barium / Q000494:pharmacology; D001692:Biological Transport / Q000187:drug effects; D003967:Diarrhea / Q000139:chemically induced*; D004285:Dogs; D004768:Enterotoxins; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006145:Guanethidine / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007408:Intestinal Absorption / Q000187:drug effects; D007422:Intestines / Q000187:drug effects*; D010424:Pentobarbital / Q000494:pharmacology; D011817:Rabbits; D013210:Staphylococcus; D013565:Sympatholytics / Q000494:pharmacology; D014118:Toxins, Biological / Q000494:pharmacology*; D014439:Tyramine / Q000494:pharmacology; D014628:Vagotomy; D014839:Vomiting / Q000139:chemically induced*
D004768:Enterotoxins; D013565:Sympatholytics; D014118:Toxins, Biological; D001464:Barium; D010424:Pentobarbital; D000109:Acetylcholine; D014439:Tyramine; D006145:Guanethidine